Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04146779 · ClinicalTrials.gov registry record · NA
Yoga Intervention in Head and Neck Cancer Patients Undergoing Concurrent Chemo-Radiation
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT04146779: Clinical Trial NA study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT04146779 is a NA study that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04146779, a NA study, was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This is a randomized prospective pilot study assessing the safety and feasibility of two yoga interventions in head and neck cancer patients undergoing primary or adjuvant radiation with or without concurrent chemotherapy
Primary Outcome
Number of adverse events as graded by CTCAE 4.0
Interventions
- BEHAVIORAL Yoga Video
- BEHAVIORAL Posture and Strengthening Video
- BEHAVIORAL Relaxation Video
- BEHAVIORAL Breath Work Video
- BEHAVIORAL Satisfaction Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-10-28 |
| Est. Completion | 2020-10-06 |
| Phase | NA |
Why NCT04146779 stopped before completion
NCT04146779 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Yoga Video is the first listed.
NCT04146779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04146779 about?
NCT04146779 is a clinical study titled "Yoga Intervention in Head and Neck Cancer Patients Undergoing Concurrent Chemo-Radiation". This is a randomized prospective pilot study assessing the safety and feasibility of two yoga interventions in head and neck cancer patients undergoing primary or adjuvant radiation with or without concurrent chemotherapy
What is the current status of trial NCT04146779?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2019-10-28. Estimated completion is 2020-10-06.
What interventions are being tested in trial NCT04146779?
The interventions under investigation include: Yoga Video (BEHAVIORAL), Posture and Strengthening Video (BEHAVIORAL), Relaxation Video (BEHAVIORAL), Breath Work Video (BEHAVIORAL), Satisfaction Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT04146779?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04146779's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI